Abstract:Background Current embolic agents in transcatheter arterial chemoembolization (TACE) of hepatocellular carcinoma (HCC) encounter instability and easy leakage, discounting TACE efficacy with residual HCC. Moreover, clinical TACE aggravates hypoxia and pro-metastatic microenvironments, rendering patients with HCC poor prognosis. Methods Herein, we developed Zein-based embolic agents that harness water-insoluble but ethanol-soluble Zein to encompass doxorubicin (DOX)-loaded mesoporous hollow MnO2 (HMnO2). The conditions and capacity of HMnO2 to generate reactive oxygen species (ROS) were assayed. Mechanical examinations of Zein-HMnO2@DOX were performed to evaluate its potential as the embolic agent. In vitro experiments were carried out to evaluate the effect of Zein-HMnO2@DOX on HCC. The subcutaneous HCC mouse model and rabbit VX2 HCC model were established to investigate its anti-tumor and anti-metastasis efficacy and explore its potential anti-tumor mechanism. Findings The high adhesion and crosslinking of Zein with HMnO2@DOX impart Zein-HMnO2@DOX with strong mechanical strength to resist deformation and wash-off. Zein gelation and HMnO2 decomposition in response to water and acidic tumor microenvironment, respectively, enable continuous DOX release and Fenton-like reaction for reactive oxygen species (ROS) production and O2 release to execute ROS-enhanced TACE. Consequently, Zeinbased embolic agents outperform clinically-used lipiodol to significantly inhibit orthotopic HCC growth. More significantly, O2 release down-regulates hypoxia inducible factor (HIF-1 alpha), vascular endothelial growth factor (VEGF) and glucose transporter protein 1 (GLUT1), which thereby re-programmes TACE-aggravated hypoxic and pro-metastatic microenvironments to repress HCC metastasis towards lung. Mechanistic explorations uncover that such Zein-based TACE agents disrupt oxidative stress, angiogenesis and glycometabolism pathways to inhibit HCC progression. Interpretation This innovative work not only provides a new TACE agent for HCC, but also establishes a new strategy to ameliorate TACE-aggravated hypoxia and metastasis motivation against clinically-common HCC metastasis after TACE operation. Copyright (c) 2024 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Monodisperse CaCO3-loaded Gelatin Microspheres for Reversing Lactic Acid-Induced Chemotherapy Resistance During TACE Treatment.

Caco3-Encapuslated Microspheres For Enhanced Transhepatic Arterial Embolization Treatment Of Hepatocellular Carcinoma

CaCO 3 ‐Encapuslated Microspheres for Enhanced Transhepatic Arterial Embolization Treatment of Hepatocellular Carcinoma

Idarubicin-loaded Degradable Hydrogel for TACE Therapy Enhances Anti-Tumor Immunity in Hepatocellular Carcinoma

Homogenous multifunctional microspheres induce ferroptosis to promote the anti-hepatocarcinoma effect of chemoembolization

Responsively Aggregatable Nanochelator-Mediated Antiangiogenesis to Enhance Interventional Therapies for Liver Cancer

Nano CaCO3 “lysosomal Bombs” Enhance Chemotherapy Drug Efficacy Via Rebalancing Tumor Intracellular Ph

Multifunctional Microspheres Dual-Loaded with Doxorubicin and Sodium Bicarbonate Nanoparticles to Introduce Synergistic Trimodal Interventional Therapy

The Studies about Doxorubicin-Loaded P(n-Isopropyl-acrylamide-co-butyl Methylacrylate) Temperature-Sensitive Nanogel Dispersions on the Application in TACE Therapies for Rabbit VX2 Liver Tumor

Biodegradable Microembolics with Nanografted Polyanions Enable High-Efficiency Drug Loading and Sustained Deep-Tumor Drug Penetration for Locoregional Chemoembolization Treatment

Polymersome-stabilized Doxorubicin-Lipiodol Emulsions for High-Efficacy Chemoembolization Therapy.

Gelation Embolism Agents Suppress Clinical TACE-incited Pro-Metastatic Microenvironment Against Hepatocellular Carcinoma Progression.

Arginine-Loaded Nano-Calcium-Phosphate-Stabilized Lipiodol Pickering Emulsions Potentiates Transarterial Embolization-Immunotherapy

Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer

Procoagulant CaCO3-embedded embolic microspheres can potentiate transcatheter arterial embolization of hepatocellular carcinoma

Synthesis and assessment of drug-eluting microspheres for transcatheter arterial chemoembolization.

Sustained Release Hypoxia-Activated Prodrug-Loaded BSA Nanoparticles Enhance Transarterial Chemoembolization Against Hepatocellular Carcinoma.

HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma

Temperature-sensitive nanogels combined with polyphosphate and cisplatin for the enhancement of tumor artery embolization by coagulation activation

Porous PLGA Microspheres with Recruited Ions and Doxorubicin for Triple-Combination Therapy of Larger Hepatocellular Carcinoma

A Novel Coacervate Embolic Agent for Tumor Chemoembolization